WHO, What, When, Where, and Why: New Classification Systems for Acute Myeloid Leukemia and Their Impact on Clinical Practice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WHO, What, When, Where, and Why: New Classification Systems for Acute Myeloid Leukemia and Their Impact on Clinical Practice
Authors
Keywords
-
Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume -, Issue -, Pages 101518
Publisher
Elsevier BV
Online
2023-10-20
DOI
10.1016/j.beha.2023.101518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia
- (2023) Brunangelo Falini et al. AMERICAN JOURNAL OF HEMATOLOGY
- Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
- (2023) Shai Shimony et al. AMERICAN JOURNAL OF HEMATOLOGY
- MOLECULAR CHARACTERIZATION OF MUTANT TP53 ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME
- (2022) Tim Grob et al. BLOOD
- TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
- (2022) Olga K Weinberg et al. Blood Advances
- Developing a Classification of Hematologic Neoplasms in the Era of Precision Medicine
- (2022) Mario Cazzola et al. BLOOD
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel
- (2022) Hartmut Döhner et al. BLOOD
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data
- (2022) Daniel A. Arber et al. BLOOD
- The WHO Classification of Haematolymphoid Tumours
- (2022) Ian A. Cree LEUKEMIA
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
- (2022) Joseph D. Khoury et al. LEUKEMIA
- Response to “The WHO classification of haematolymphoid tumours” (Editorial)
- (2022) Steven H. Swerdlow et al. LEUKEMIA
- AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?
- (2022) Sandra Huber et al. BLOOD
- What is in a Name? Consequences of the Classification Schism in Hematopathology
- (2022) Jon C. Aster JOURNAL OF CLINICAL ONCOLOGY
- CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome
- (2021) Franziska Taube et al. BLOOD
- Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
- (2021) Satoshi Wakita et al. Blood Advances
- Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
- (2020) Nicholas J. Short et al. JAMA Oncology
- Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts
- (2019) Linus Angenendt et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search